Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) EBITDA Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed EBITDA Margin for 3 consecutive years, with 45960.77% as the latest value for Q1 2018.

  • Quarterly EBITDA Margin changed N/A to 45960.77% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 146080.47% through Dec 2018, down 14476512.0% year-over-year, with the annual reading at 8091.52% for FY2025, 187968.0% up from the prior year.
  • EBITDA Margin for Q1 2018 was 45960.77% at ENDRA Life Sciences, down from 33526.58% in the prior quarter.
  • The five-year high for EBITDA Margin was 210.52% in Q2 2016, with the low at 45960.77% in Q1 2018.
  • Average EBITDA Margin over 3 years is 13580.91%, with a median of 1073.38% recorded in 2017.
  • Peak annual rise in EBITDA Margin hit -203988bps in 2017, while the deepest fall reached -3346474bps in 2017.
  • Over 3 years, EBITDA Margin stood at 61.85% in 2016, then tumbled by -54107bps to 33526.58% in 2017, then crashed by -37bps to 45960.77% in 2018.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 45960.77%, 33526.58%, and 317.4% for Q1 2018, Q4 2017, and Q3 2017 respectively.